Annual Congress Copenhagen 2005


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show


New strategies and drugs for smoking cessation

Hot topics
Chairs: C. Gratziou (Athens, Greece), L. Allegra (Milano, Italy)
Tobacco smoking is the most important cause of lung diseases, and smoking cessation is the first and most important therapy to be used in many of the most prevalent among them. Tobacco smoking is a disease in itself; to heal from it is difficult. Failure and relapses are very frequent and, in most smokers, smoking is a chronic condition. There are drugs which can be successfully used for helping smokers to quit: with these drugs the healing is easier even if the long-term success rates remain under 50%. In chest medicine, smoking cessation should always be achieved (in smoking lung patients) and drugs effective in smoking cessation widely prescribed. Smoking cessation and smoking reduction should be included in the routinary clinical practice of every chest physician.

Download all media Download all media
 [+]  Slide presentation Webcast 1313 How to predict COPD in a clinical setting
C. Jimenez Ruiz (Madrid, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Slide presentation Webcast 1314 New drug for smoking cessation: rimonabant
P. Tonnesen (Gentofte, Denmark)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Slide presentation Webcast 1315 New drug for smoking cessation: varenicline
K. Fagerstrom (Helsingborg, Sweden)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 No content
  made available
1316 The use of a nicotine vaccine in smoking cessation
J. Cornuz (Lausanne, Switzerland)